GLP1R and early-onset autosomal dominant Alzheimer disease: The GLP-1 receptors (GLP-1R) are expressed throughout the brain, and its signaling has been recognized to exert neuroprotective and neurotrophic effects in various experimental models of neurodegenerative diseases, including Alzheimer's disease, Parkinson’s disease, ALS, and ischemic brain injury [71].